Substance Use Tools & Resources    

Explains whether opioid pain medications are safe for women who are pregnant or planning to become pregnant. Provides information about whether these patients should stop taking pain medication if they find out they are pregnant and whether breastfeeding women should continue medication.

Provides information about treatment with methadone and buprenorphine for pregnant women.

Addresses concerns about prescription drug abuse and maternal-fetal exposure to opioids.

Provides information for treating pregnant and parenting women with OUD, as well as their infants.

Discusses how prenatal opioid exposure affects the health and wellness of women and their newborns and identifies effective strategies to address barriers to care for women and newborns affected by perinatal substance use disorder and NAS.

Emphasizes the importance of continuing a mother’s treatment for OUD throughout pregnancy. Includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, treatment of prenatal opioid exposure, and considerations to address before hospital discharge.

Explores effective interagency policy and initiative strategies that officials in Colorado, Pennsylvania, and Texas have used to treat and support pregnant and parenting women with substance use disorder

This module introduces family support professionals and other service providers to basic information about the importance of medication compliance, and provides an understanding of how pregnant and parenting women being treated for behavioral health or medical conditions may be non-compliant or misuse medications. It prepares service providers to recognize women who may be at risk for noncompliance or misuse of medications, develop a plan for referral, and support women with behavioral health problems or medical condition.

The Council on Patient Safety in Women’s Health Care disseminates patient safety bundles to help facilitate the standardization process. This bundle reflects emerging clinical, scientific, and patient safety advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Although the components of a particular bundle may be adapted to local resources, standardization within an institution is strongly encouraged.

This toolkit provides tools to both providers and patients for the assessment and management of perinatal mood and anxiety disorders, as well as substance use disorders (SUD).